Abrdn Life Sciences Investors (HQL) News Today → Trump Reveals Conspiracy Behind Fed-Controlled Digital Currency. (From Monetary Gold) (Ad) Free HQL Stock Alerts $14.23 -0.03 (-0.21%) (As of 02:03 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsDividendFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsDividendFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 5:52 AM | americanbankingnews.comSaba Capital Management, L.P. Acquires 57,862 Shares of Abrdn Life Sciences Investors (NYSE:HQL) StockMay 15 at 7:19 AM | insidertrades.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Acquires 57,862 SharesMay 14 at 3:43 PM | marketbeat.comSaba Capital Management, L.P. Purchases 57,862 Shares of Abrdn Life Sciences Investors (NYSE:HQL) StockAbrdn Life Sciences Investors (NYSE:HQL - Get Free Report) major shareholder Saba Capital Management, L.P. purchased 57,862 shares of the stock in a transaction dated Friday, May 10th. The stock was acquired at an average price of $13.86 per share, for a total transaction of $801,967.32. Following the completion of the transaction, the insider now directly owns 3,215,825 shares of the company's stock, valued at $44,571,334.50. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Major shareholders that own more than 10% of a company's shares are required to disclose their transactions with the SEC.May 12, 2024 | uk.investing.comSaba Capital Management buys abrdn Life Sciences shares worth $390kMay 12, 2024 | americanbankingnews.comSaba Capital Management, L.P. Acquires 10,986 Shares of Abrdn Life Sciences Investors (NYSE:HQL) StockMay 11, 2024 | insidertrades.comSaba Capital Management, L.P. Buys 10,986 Shares of Abrdn Life Sciences Investors (NYSE:HQL) StockMay 10, 2024 | marketbeat.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Purchases 10,986 SharesAbrdn Life Sciences Investors (NYSE:HQL - Get Free Report) major shareholder Saba Capital Management, L.P. bought 10,986 shares of the firm's stock in a transaction on Wednesday, May 8th. The stock was purchased at an average cost of $13.70 per share, for a total transaction of $150,508.20. Following the completion of the acquisition, the insider now owns 3,140,590 shares in the company, valued at $43,026,083. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Major shareholders that own 10% or more of a company's shares are required to disclose their transactions with the SEC.May 9, 2024 | americanbankingnews.comSaba Capital Management, L.P. Buys 10,713 Shares of Abrdn Life Sciences Investors (NYSE:HQL) StockMay 8, 2024 | insidertrades.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Purchases 10,713 SharesMay 7, 2024 | marketbeat.comInsider Buying: Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Acquires 10,713 Shares of StockAbrdn Life Sciences Investors (NYSE:HQL - Get Free Report) major shareholder Saba Capital Management, L.P. purchased 10,713 shares of Abrdn Life Sciences Investors stock in a transaction dated Monday, May 6th. The shares were bought at an average price of $13.62 per share, with a total value of $145,911.06. Following the completion of the acquisition, the insider now directly owns 3,079,443 shares of the company's stock, valued at $41,942,013.66. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Large shareholders that own 10% or more of a company's shares are required to disclose their sales and purchases with the SEC.May 3, 2024 | insidertrades.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Purchases $353,648.04 in StockMay 2, 2024 | marketbeat.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Acquires 26,274 SharesAbrdn Life Sciences Investors (NYSE:HQL - Get Free Report) major shareholder Saba Capital Management, L.P. acquired 26,274 shares of the business's stock in a transaction dated Thursday, May 2nd. The shares were bought at an average price of $13.46 per share, for a total transaction of $353,648.04. Following the completion of the acquisition, the insider now owns 3,068,730 shares in the company, valued at $41,305,105.80. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. Large shareholders that own at least 10% of a company's shares are required to disclose their transactions with the SEC.May 2, 2024 | insidertrades.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Buys 16,573 SharesMay 1, 2024 | marketbeat.comInsider Buying: Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Purchases 16,573 Shares of StockAbrdn Life Sciences Investors (NYSE:HQL - Get Free Report) major shareholder Saba Capital Management, L.P. acquired 16,573 shares of the firm's stock in a transaction that occurred on Tuesday, April 30th. The shares were bought at an average price of $13.13 per share, with a total value of $217,603.49. Following the acquisition, the insider now directly owns 3,042,204 shares in the company, valued at $39,944,138.52. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Large shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.April 30, 2024 | insidertrades.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Buys 120,304 SharesApril 30, 2024 | markets.businessinsider.comXlife Sciences AG Reports Strong Portfolio Growth and Strategic Advances in the 2023 Valuation ReportApril 29, 2024 | marketbeat.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Acquires 120,304 SharesAbrdn Life Sciences Investors (NYSE:HQL - Get Free Report) major shareholder Saba Capital Management, L.P. acquired 120,304 shares of the stock in a transaction that occurred on Friday, April 26th. The shares were bought at an average price of $13.00 per share, with a total value of $1,563,952.00. Following the completion of the transaction, the insider now owns 3,025,602 shares in the company, valued at $39,332,826. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Large shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.April 27, 2024 | insidertrades.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Acquires 20,529 SharesApril 26, 2024 | marketbeat.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Buys 20,529 SharesAbrdn Life Sciences Investors (NYSE:HQL - Get Free Report) major shareholder Saba Capital Management, L.P. bought 20,529 shares of the firm's stock in a transaction that occurred on Wednesday, April 24th. The stock was purchased at an average cost of $13.12 per share, with a total value of $269,340.48. Following the completion of the transaction, the insider now owns 2,807,724 shares in the company, valued at $36,837,338.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Major shareholders that own more than 10% of a company's shares are required to disclose their sales and purchases with the SEC.April 24, 2024 | marketbeat.comWolverine Asset Management LLC Sells 114,766 Shares of Abrdn Life Sciences Investors (NYSE:HQL)Wolverine Asset Management LLC decreased its holdings in shares of Abrdn Life Sciences Investors (NYSE:HQL - Free Report) by 35.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 207,392April 24, 2024 | insidertrades.comInsider Buying: Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Acquires 2,022 Shares of StockApril 23, 2024 | marketbeat.comSaba Capital Management, L.P. Buys 2,022 Shares of Abrdn Life Sciences Investors (NYSE:HQL) StockAbrdn Life Sciences Investors (NYSE:HQL - Get Free Report) major shareholder Saba Capital Management, L.P. acquired 2,022 shares of the stock in a transaction dated Monday, April 22nd. The shares were bought at an average cost of $12.88 per share, for a total transaction of $26,043.36. Following the acquisition, the insider now owns 2,738,992 shares in the company, valued at approximately $35,278,216.96. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Major shareholders that own at least 10% of a company's shares are required to disclose their transactions with the SEC.April 23, 2024 | insidertrades.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Acquires $1,046,246.40 in StockApril 22, 2024 | marketbeat.comSaba Capital Management, L.P. Purchases 81,738 Shares of Abrdn Life Sciences Investors (NYSE:HQL) StockAbrdn Life Sciences Investors (NYSE:HQL - Get Free Report) major shareholder Saba Capital Management, L.P. purchased 81,738 shares of the company's stock in a transaction on Thursday, April 18th. The shares were purchased at an average price of $12.80 per share, with a total value of $1,046,246.40. Following the completion of the purchase, the insider now directly owns 2,694,511 shares of the company's stock, valued at $34,489,740.80. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Major shareholders that own 10% or more of a company's stock are required to disclose their sales and purchases with the SEC.April 19, 2024 | marketbeat.comAbrdn Life Sciences Investors (NYSE:HQL) Shares Bought by Allspring Global Investments Holdings LLCAllspring Global Investments Holdings LLC lifted its position in shares of Abrdn Life Sciences Investors (NYSE:HQL - Free Report) by 30.6% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 454,154 shares of the company's stock afteApril 11, 2024 | marketbeat.comRaymond James Financial Services Advisors Inc. Has $1.76 Million Position in Abrdn Life Sciences Investors (NYSE:HQL)Raymond James Financial Services Advisors Inc. grew its stake in Abrdn Life Sciences Investors (NYSE:HQL - Free Report) by 183.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 131,077 sharMarch 21, 2024 | finance.yahoo.comabrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Healthcare Opportunities Fund (THQ), and abrdn World Healthcare Fund (THW) Announce Investment Team UpdateMarch 13, 2024 | marketbeat.comAbrdn Life Sciences Investors (NYSE:HQL) Sees Significant Decrease in Short InterestAbrdn Life Sciences Investors (NYSE:HQL - Get Free Report) was the target of a large decline in short interest during the month of February. As of February 29th, there was short interest totalling 56,000 shares, a decline of 58.0% from the February 14th total of 133,400 shares. Based on an average trading volume of 130,100 shares, the days-to-cover ratio is currently 0.4 days.March 8, 2024 | msn.comSYRA: Takeaways from Life Science Investor Forum PresentationMarch 1, 2024 | bizjournals.comA 2024 life sciences outlook in Boston – and beyondFebruary 27, 2024 | marketbeat.comClough Capital Partners L P Acquires New Stake in Abrdn Life Sciences Investors (NYSE:HQL)Clough Capital Partners L P purchased a new stake in Abrdn Life Sciences Investors (NYSE:HQL - Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 130,450 shares of the company'sFebruary 19, 2024 | marketbeat.comQuantedge Capital Pte Ltd Has $1.18 Million Stock Position in Abrdn Life Sciences Investors (NYSE:HQL)Quantedge Capital Pte Ltd grew its holdings in shares of Abrdn Life Sciences Investors (NYSE:HQL - Free Report) by 60.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 94,420 shares of the company's stock afteFebruary 19, 2024 | marketbeat.comAbrdn Life Sciences Investors (NYSE:HQL) Raises Dividend to $0.39 Per ShareAbrdn Life Sciences Investors (NYSE:HQL) declared a quarterly dividend on Friday, February 9th. Shareholders of record on Thursday, February 22nd will be given a dividend of 0.39 per share on Thursday, March 28th. This represents a $1.56 dividend on an annualized basis and a yield of 11.06%. The ex-dividend date of this dividend is Wednesday, February 21st. This is a boost from Abrdn Life Sciences Investors's previous quarterly dividend of $0.30.February 9, 2024 | markets.businessinsider.comabrdn Life Sciences Investors (HQL) and abrdn Healthcare Investors (HQH) Announce a 25% Increase in Distribution Rates and abrdn Healthcare Opportunities Fund (THQ) Announces a 60% Increase in...February 5, 2024 | marketbeat.comRaymond James & Associates Sells 136,694 Shares of abrdn Life Sciences Investors (NYSE:HQL)Raymond James & Associates reduced its stake in abrdn Life Sciences Investors (NYSE:HQL - Free Report) by 83.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 27,771 shares of the company's stock after selling 136January 28, 2024 | marketbeat.comabrdn Life Sciences Investors (NYSE:HQL) is Rpo LLC's 6th Largest PositionRpo LLC increased its holdings in abrdn Life Sciences Investors (NYSE:HQL - Free Report) by 75.7% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 327,042 shares of the company's stock after purchasing an additional 140,942 shares duringJanuary 24, 2024 | benzinga.comPeering Into Anavex Life Sciences's Recent Short InterestJanuary 4, 2024 | marketbeat.comTodd Reit Acquires 1,000 Shares of abrdn Life Sciences Investors (NYSE:HQL) Stockabrdn Life Sciences Investors (NYSE:HQL - Get Free Report) Director Todd Reit bought 1,000 shares of the business's stock in a transaction dated Tuesday, January 2nd. The stock was purchased at an average price of $13.80 per share, with a total value of $13,800.00. Following the purchase, the director now directly owns 1,000 shares of the company's stock, valued at approximately $13,800. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.January 1, 2024 | marketbeat.comabrdn Life Sciences Investors (NYSE:HQL) Sees Large Growth in Short Interestabrdn Life Sciences Investors (NYSE:HQL - Get Free Report) saw a large increase in short interest in the month of December. As of December 15th, there was short interest totalling 54,300 shares, an increase of 18.0% from the November 30th total of 46,000 shares. Based on an average daily volume of 136,000 shares, the short-interest ratio is presently 0.4 days.November 23, 2023 | money.usnews.comabrdn Life Sciences InvestorsNovember 2, 2023 | investing.comAbrdn Life Sciences Investors (HQL)September 26, 2023 | finance.yahoo.comInsider Buying: President Daniel Omstead Acquires 10,096 Shares of Tekla Life Sciences ...September 21, 2023 | finance.yahoo.comInsider Buying: President Daniel Omstead Acquires 12,000 Shares of Tekla Life Sciences ...September 20, 2023 | marketbeat.comAtlantic Union Bankshares Corp Sells 9,774 Shares of Tekla Life Sciences Investors (NYSE:HQL)Atlantic Union Bankshares Corp lessened its holdings in shares of Tekla Life Sciences Investors (NYSE:HQL - Free Report) by 19.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,548 shares of the comSeptember 6, 2023 | marketbeat.comPrivate Advisor Group LLC Makes New $273,000 Investment in Tekla Life Sciences Investors (NYSE:HQL)Private Advisor Group LLC purchased a new position in shares of Tekla Life Sciences Investors (NYSE:HQL - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 19,587 shares of the company's stock, valuedAugust 15, 2023 | seekingalpha.comTekla Life Sciences declares $0.32 dividendAugust 12, 2023 | marketbeat.comTekla Life Sciences Investors (NYSE:HQL) Short Interest UpdateTekla Life Sciences Investors (NYSE:HQL - Get Free Report) saw a significant increase in short interest in the month of July. As of July 31st, there was short interest totalling 40,500 shares, an increase of 282.1% from the July 15th total of 10,600 shares. Based on an average daily volume of 90,400 shares, the days-to-cover ratio is presently 0.4 days.July 14, 2023 | marketbeat.comShort Interest in Tekla Life Sciences Investors (NYSE:HQL) Rises By 695.7%Tekla Life Sciences Investors (NYSE:HQL - Get Free Report) was the recipient of a large increase in short interest in the month of June. As of June 30th, there was short interest totalling 74,000 shares, an increase of 695.7% from the June 15th total of 9,300 shares. Based on an average daily volume of 74,000 shares, the short-interest ratio is presently 1.0 days.July 12, 2023 | marketbeat.comRaymond James & Associates Boosts Stock Position in Tekla Life Sciences Investors (NYSE:HQL)Raymond James & Associates lifted its holdings in shares of Tekla Life Sciences Investors (NYSE:HQL - Free Report) by 21.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 310,204 shares of the company's stJuly 7, 2023 | marketbeat.comAllspring Global Investments Holdings LLC Acquires 62,721 Shares of Tekla Life Sciences Investors (NYSE:HQL)Allspring Global Investments Holdings LLC boosted its holdings in Tekla Life Sciences Investors (NYSE:HQL - Free Report) by 40.2% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 218,605 shares of the company's Get Abrdn Life Sciences Investors News Delivered to You Automatically Sign up to receive the latest news and ratings for HQL and its competitors with MarketBeat's FREE daily newsletter. Email Address Tiny AI projects with huge promise hiding in plain sight … (Ad)I’ve developed a system that’s helped me find huge winners in the past. Now my system has alerted me to the next four altcoins that could be the next superstars. Click here to find out who they are. HQL Media Mentions By Week HQL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HQL News Sentiment▼1.290.66▲Average Finance News Sentiment HQL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HQL Articles This Week▼111▲HQL Articles Average Week Get Abrdn Life Sciences Investors News Delivered to You Automatically Sign up to receive the latest news and ratings for HQL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MCI News Today KTF News Today TYG News Today MYN News Today SOR News Today PPT News Today HRZN News Today MIY News Today MUA News Today MHN News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:HQL) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abrdn Life Sciences Investors Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
